No price history available.
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 192 | 212 | 266 | 295 | 388 | 477 | N/A | N/A |
| Operating profit | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | £m | 37 | 58 | 121 | 71 | 65 | 42 | N/A | N/A |
| EPS reported | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | £m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | £ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Bridgepoint Group plc, formerly Bridgepoint Group Limited, is a financial institution specializing in both private equity and private credit. The firm deploys capital across diverse investment strategies, including growth capital, buyouts, syndicated debt, infrastructure financing, direct lending, and various private credit opportunities. It targets companies ranging from lower mid-market and middle market to small mid-cap and small-cap segments. Bridgepoint's investment focus spans a wide array of sectors. These include advanced industrials, automation, agricultural sciences, and businesses facilitating the energy transition. It also actively invests in business services, financial services, professional services, testing, inspection, and certification (TIC), and information services. Within the consumer domain, the firm backs digital brands, video games, and wellbeing products. Additionally, Bridgepoint has a significant presence in healthcare, particularly in pharmaceuticals, Med-Tech products, and outsourced Med-Tech services. Geographically, the firm primarily seeks opportunities across the United Kingdom, New York, Germany, Austria, Switzerland, Spain, France, and the Nordic region. Equity investments generally range from £4.77 million (approximately $5.91 million) to €300 million (around $348.8 million). Specifically, commitments for small mid-cap companies are typically between £40 million ($49.54 million) and £125 million ($154.82 million), while small-cap investments are usually between £10 million ($12.39 million) and £25 million ($30.96 million). Bridgepoint focuses on businesses with an enterprise value ranging from €10 million (about $10.74 million) to €1 billion (approximately $1.07 billion). Established in 1985, Bridgepoint Group plc is headquartered in London, United Kingdom, and maintains a global operational presence with additional offices across North America, Asia, and Europe.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Bridgepoint Group plc (BPT.L)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Bridgepoint Group plc, formerly Bridgepoint Group Limited, is a financial institution specializing in both private equity and private credit. The firm deploys capital across diverse investment strategies, including growth capital, buyouts, syndicated debt, infrastructure financing, direct lending, and various private credit opportunities. It targets companies ranging from lower mid-market and middle market to small mid-cap and small-cap segments. Bridgepoint's investment focus spans a wide array of sectors. These include advanced industrials, automation, agricultural sciences, and businesses facilitating the energy transition. It also actively invests in business services, financial services, professional services, testing, inspection, and certification (TIC), and information services. Within the consumer domain, the firm backs digital brands, video games, and wellbeing products. Additionally, Bridgepoint has a significant presence in healthcare, particularly in pharmaceuticals, Med-Tech products, and outsourced Med-Tech services. Geographically, the firm primarily seeks opportunities across the United Kingdom, New York, Germany, Austria, Switzerland, Spain, France, and the Nordic region. Equity investments generally range from £4.77 million (approximately $5.91 million) to €300 million (around $348.8 million). Specifically, commitments for small mid-cap companies are typically between £40 million ($49.54 million) and £125 million ($154.82 million), while small-cap investments are usually between £10 million ($12.39 million) and £25 million ($30.96 million). Bridgepoint focuses on businesses with an enterprise value ranging from €10 million (about $10.74 million) to €1 billion (approximately $1.07 billion). Established in 1985, Bridgepoint Group plc is headquartered in London, United Kingdom, and maintains a global operational presence with additional offices across North America, Asia, and Europe.